Cargando…

Efficacy of covered and bare stent in TIPS for cirrhotic portal hypertension: A single-center randomized trial

We conducted a single-center randomized trial to compare the efficacy of 8 mm Fluency covered stent and bare stent in transjugular intrahepatic portosystemic shunt (TIPS) for cirrhotic portal hypertension. From January 2006 to December 2010, the covered (experimental group) or bare stent (control gr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Lei, Xiao, Zhibo, Yue, Zhendong, Zhao, Hongwei, Fan, Zhenhua, Zhao, Mengfei, He, Fuliang, Dai, Shan, Qiu, Bin, Yao, Jiannan, Lin, Qiushi, Dong, Xiaoqun, Liu, Fuquan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753460/ https://www.ncbi.nlm.nih.gov/pubmed/26876503 http://dx.doi.org/10.1038/srep21011

Ejemplares similares

Techniques of TIPS in the treatment of liver cirrhosis combined with incompletely occlusive main portal vein thrombosis
por: Zhao, Mengfei, et al.
Publicado: (2016)

Techniques and long-term effects of transjugular intrahepatic portosystemic shunt on liver cirrhosis-related thrombotic total occlusion of main portal vein
por: Wang, Lei, et al.
Publicado: (2017)

Benefits of Early Treatment for Patients with Hepatic Myelopathy Secondary to TIPS: A Retrospective Study in Northern China
por: Zhao, Hongwei, et al.
Publicado: (2018)

Pathological Predictors of Shunt Stenosis and Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt
por: He, Fuliang, et al.
Publicado: (2016)

Innovative angiography: a new approach to discover more hepatic vein collaterals in patients with cirrhotic portal hypertension
por: Liu, Bowen, et al.
Publicado: (2023)

Outcomes of covered stents versus bare-metal stents for subclavian artery occlusive disease
por: Wei, Libing, et al.
Publicado: (2023)

The Effect of Puncture Sites of Portal Vein in TIPS with ePTFE-Covered Stents on Postoperative Long-Term Clinical Efficacy
por: Chen, Si-liang, et al.
Publicado: (2019)

Gastrointestinal Bleeding in Cirrhotic Patients with Portal Hypertension
por: Biecker, Erwin
Publicado: (2013)

Causes and Management of Non-cirrhotic Portal Hypertension
por: Gioia, Stefania, et al.
Publicado: (2020)

The Role of miRNA-34a as a Prognostic Biomarker for Cirrhotic Patients with Portal Hypertension Receiving TIPS
por: Jansen, Christian, et al.
Publicado: (2014)

Child-Na Score: A Predictive Model for Survival in Cirrhotic Patients with Symptomatic Portal Hypertension Treated with TIPS
por: Chen, Hui, et al.
Publicado: (2013)

The effects and safety of anticoagulation or antiplatelet therapy following TIPS in cirrhotic patients with portal hypertension: A meta-analysis
por: Xu, Xiaotong, et al.
Publicado: (2023)

Transjugular intrahepatic portosystemic shunt for Budd–Chiari syndrome with diffuse occlusion of hepatic veins
por: He, Fuliang, et al.
Publicado: (2016)

A New Concept for Carotid Artery Stenting: Coating the Atherosclerotic Plaque by Covered Stent before Bare Stent Implantation
por: Akgul, Erol
Publicado: (2016)

Wall shear stress in portal vein of cirrhotic patients with portal hypertension
por: Wei, Wei, et al.
Publicado: (2017)

Clinical efficacy of transjugular intrahepatic portosystemic shunt in the treatment of hepatopulmonary syndrome
por: Zhao, Hongwei, et al.
Publicado: (2017)

Association of hepatic vein Lipiodol tram-track sign during transcatheter arterial chemoembolization with perioperative death
por: Zhao, Hongwei, et al.
Publicado: (2017)

The Impact of Partial Splenic Embolization on Portal Hypertensive Gastropathy in Cirrhotic Patients with Portal Hypertension
por: Saeki, Michio, et al.
Publicado: (2023)

Cardiac dysfunction in cirrhotic portal hypertension with or without ascites
por: Dadhich, Sunil, et al.
Publicado: (2014)

Idiopathic non-cirrhotic portal hypertension: a review
por: Schouten, Jeoffrey NL, et al.
Publicado: (2015)

The beneficial effects of curcumin in cirrhotic rats with portal hypertension
por: Hsu, Shao-Jung, et al.
Publicado: (2017)

Research progress on signaling pathways in cirrhotic portal hypertension
por: Xu, Wen, et al.
Publicado: (2018)

Cirrhotic portal hypertension: From pathophysiology to novel therapeutics
por: Gunarathne, Lakmie S, et al.
Publicado: (2020)

Non-cirrhotic portal hypertension in an ankylosing spondylitis patient
por: Park, Sukki, et al.
Publicado: (2018)

Non-Cirrhotic Portal Hypertension in Systemic Lupus Erythematosus
por: Suárez-Díaz, Silvia, et al.
Publicado: (2023)

Statins activate the canonical hedgehog-signaling and aggravate non-cirrhotic portal hypertension, but inhibit the non-canonical hedgehog signaling and cirrhotic portal hypertension
por: Uschner, Frank E., et al.
Publicado: (2015)

A meta-analysis of combined generic-covered stent-graft with or without bare-metal stent for refractory variceal bleeding
por: Ren, Hongcheng, et al.
Publicado: (2022)

A133 PORTAL VENOUS STENTING FOR THE TREATMENT OF NON-CIRRHOTIC PORTAL HYPERTENSION-RELATED GASTRIC ANTRAL VASCULAR ECTASIA: A CASE REPORT
por: Deeb, M, et al.
Publicado: (2023)

Splenic arteriovenous fistula leading to non-cirrhotic portal hypertension: a case report: Splenic arteriovenous fistula leading to non-cirrhotic portal hypertension
por: Abou Yassine, Ahmad, et al.
Publicado: (2023)

Nitro-oxidative stress, VEGF and MMP-9 in patients with cirrhotic and non-cirrhotic portal hypertension
por: MUTI, LEON ADRIAN, et al.
Publicado: (2015)

Pathological abnormalities in splenic vasculature in non-cirrhotic portal hypertension: Its relevance in the management of portal hypertension
por: Gupta, Shahana, et al.
Publicado: (2020)

Long-term efficacy of subtotal splenectomy due to portal hypertension in cirrhotic patients
por: Chu, Haibo, et al.
Publicado: (2015)

Phosphodiesterases in the Liver as Potential Therapeutic Targets of Cirrhotic Portal Hypertension
por: Kreisel, Wolfgang, et al.
Publicado: (2020)

Chronic Myeloid Leukemia Presenting as Non-cirrhotic Portal Hypertension
por: Gemnani, Rinkle R, et al.
Publicado: (2023)

A new choice of stent for transjugular intrahepatic portosystemic shunt creation: Viabahn ePTFE covered stent/bare metal stent combination
por: Liu, Jiacheng, et al.
Publicado: (2020)

Covered vs bare stent for distal malignant biliary obstruction due to primary common biliary cancer
por: Tang, Ling, et al.
Publicado: (2021)

No Differences in Rotational Thromboelastometry Measurements between Portal and Peripheral Circulation in Cirrhotic Patients Undergoing TIPS
por: Bedreli, Sotiria, et al.
Publicado: (2023)

Transcriptome analysis of mesenteric arterioles changes and its mechanisms in cirrhotic rats with portal hypertension
por: Wu, Guangbo, et al.
Publicado: (2023)

PTFE-covered TIPS is an effective treatment for secondary preventing variceal rebleeding in cirrhotic patients with high risks
por: Zhou, Yongjie, et al.
Publicado: (2020)

Covered versus bare stents for transjugular intrahepatic portosystemic shunt: an updated meta-analysis of randomized controlled trials
por: Qi, Xingshun, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_mlch9iat63nks7tf5upd3eb8fb